More recently, a novel mechanism of tumor evasion from immune control based on ILC plasticity and guided by TGF-β has been proposed by Gao et al., who described the TGF-β mediated conversion of NK cells into ILC1s in different tumor models [10]. This evidence concerns the gene TGFB1 and neoplasm.